Abstract
Animal studies suggest the involvement of natriuretic peptides (NP) in several brain functions that are known to be disturbed during Alzheimer’s disease (AD). However, it remains unclear whether such findings extend to humans. In this study, we aimed to: (1) map the gene expression and localization of NP and their receptors (NPR) in human post-mortem brain tissue; (2) compare the relative amounts of NP and NPR between the brain tissue of AD patients and non-demented controls, and (3) compare the relative amounts of NP between the cerebrospinal fluid (CSF) of AD patients and non-demented controls. Using the publicly available Allen Human Brain Atlas dataset, we mapped the gene expression of NP and NPR in healthy humans. Using immunohistochemistry, we visualized the localization of NP and NPR in the frontal cortex of AD patients (n = 10, mean age 85.8 ± 6.2 years) and non-demented controls (mean age = 80.2 ± 9.1 years). Using Western blotting and ELISA, we quantified the relative amounts of NP and NPR in the brain tissue and CSF of these AD patients and non-demented controls. Our results showed that NP and NPR genes were ubiquitously expressed throughout the brain in healthy humans. NP and NPR were present in various cellular structures including in neurons, astrocyte-like structures, and cerebral vessels in both AD patients and non-demented controls. Furthermore, we found higher amounts of NPR type-A in the brain of AD patients (p = 0.045) and lower amounts of NP type-B in the CSF of AD patients (p = 0.029). In conclusion, this study shows the abundance of NP and NPR in the brain of humans suggesting involvement of NP in various brain functions. In addition, our findings suggest alterations of NP levels in the brain of AD patients. The role of NP in the development and progression of AD remains to be elucidated.
Highlights
Natriuretic peptides (NP) refer to a group of peptides that are mostly known for their actions within the cardiovascular system (Potter et al, 2006)
We first showed that the genes coding for NP and NP and their receptors (NPR) are ubiquitously expressed across the brain of healthy humans
When comparing between Alzheimer’s disease (AD) patients and non-demented controls, natriuretic peptide receptor A (NPR-A) levels were higher in the brain tissue of AD patients while brain natriuretic peptide (BNP) levels were lower in the cerebrospinal fluid (CSF) of AD patients
Summary
Natriuretic peptides (NP) refer to a group of peptides that are mostly known for their actions within the cardiovascular system (Potter et al, 2006). NP regulate body fluid homeostasis by inducing natriuresis, diuresis, vasodilation and lowering blood pressure (Potter et al, 2006). Three members of this family are atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) (Suzuki et al, 2001). While NP were initially discovered in cardiac myocytes (de Bold et al, 1981), extensive distribution of NP and their receptors in the brain of animal species has been repeatedly reported (Cao and Yang, 2008). Findings from animal studies suggest that NP may regulate neuroplasticity (Decker et al, 2010), blood-brain barrier integrity (Bohara et al, 2014), neuro-inflammation (Moriyama et al, 2006; James et al, 2010) and memory function (Telegdy et al, 2000; Decker et al, 2009)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
